Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients.
Sokolenko AP, Moiseyenko FV, Iyevleva AG, Ivantsov AO, Dolmatov GD, Shelekhova KV, Gulo EV, Topal AX, Artemieva EV, Abduloeva NH, Rysev NA, Barsova DA, Levchenko NV, Volkov NM, Egorenkov VV, Moiseyenko VM, Imyanitov EN. Sokolenko AP, et al. Among authors: egorenkov vv. Int J Mol Sci. 2023 Jan 18;24(3):1870. doi: 10.3390/ijms24031870. Int J Mol Sci. 2023. PMID: 36768191 Free PMC article.
Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation.
Moiseyenko FV, Egorenkov VV, Kramchaninov MM, Artemieva EV, Aleksakhina SN, Holmatov MM, Moiseyenko VM, Imyanitov EN. Moiseyenko FV, et al. Among authors: egorenkov vv. Case Rep Oncol. 2019 May 16;12(2):339-343. doi: 10.1159/000500481. eCollection 2019 May-Aug. Case Rep Oncol. 2019. PMID: 31182949 Free PMC article.
Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome.
Moiseenko FV, Volkov NM, Zhabina AS, Stepanova ML, Rysev NA, Klimenko VV, Myslik AV, Artemieva EV, Egorenkov VV, Abduloeva NH, Ivantsov AO, Kuligina ES, Imyanitov EN, Moiseyenko VM. Moiseenko FV, et al. Among authors: egorenkov vv. Cancer Treat Res Commun. 2022;31:100524. doi: 10.1016/j.ctarc.2022.100524. Epub 2022 Jan 31. Cancer Treat Res Commun. 2022. PMID: 35101831 Free article. Clinical Trial.
The emergence of hypervirulent blaNDM-1-positive Klebsiella pneumoniae sequence type 395 in an oncology hospital.
Lazareva I, Ageevets V, Sopova J, Lebedeva M, Starkova P, Likholetova D, Lebedeva M, Gostev V, Moiseenko V, Egorenkov V, Navatskaya A, Mitroshina G, Myasnikova E, Tsvetkova I, Lobzin Y, Sidorenko S. Lazareva I, et al. Infect Genet Evol. 2020 Nov;85:104527. doi: 10.1016/j.meegid.2020.104527. Epub 2020 Sep 6. Infect Genet Evol. 2020. PMID: 32898687
[Cutaneous melanoma: clinico-morphological analysis of current diagnostics].
Gafton GI, Semiletova IuV, Anisimov VV, Matsko DE, Lemekhov VG, Egorenkov VV, Kochnev VA, Petrov VG, Shchukin VV, Gafton IG, Malykh IIu. Gafton GI, et al. Among authors: egorenkov vv. Vopr Onkol. 2012;58(2):286-8. Vopr Onkol. 2012. PMID: 22774539 Russian. No abstract available.
13 results